Differentiated thyroid cancers

Česká verzia

Authors: Kateřina Táborská
Authors place of work: Klinika nukleární medicíny a endokrinologie, 2. LF UK a FN v Motole, Praha
Published in the journal: NuklMed 2014;3:44
Category: Editorial

Zdroje

1. Pellegriti G, Frasca F, Regalbuto C et al. Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors. Journal of Cancer Epidemiology [online]. 2013. [cit. 2014-01-08] ]. Dostupné na: http://dx.doi.org/10.1155/2013/96521

2. Seidlin SM, Marinell LD, Oshry E. Radioactive iodine therapy: Effect on Functioning Metastases of Adenocarcinoma of the Thyroid. JAMA 1946;132:838-847

3. Pacini F, Schlumberger M, Dralle H et al. European consensus for management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787-803

4. Schlumberger M, Catargi B, Borget I et al. Strategies of radioidine ablation in patients with low risk thyroid cancer. The New England Journal of Medicine 2012;366:1663-1673

5. Bendlová B, Dvořáková Š, Sýkorová V et al. Genetika nádorů štítné žlázy a jejich molekulárně cílená léčba. Onkologie 2011;5:325-329

Štítky

Nuclear medicine Radiodiagnostics Radiotherapy

Článek Quantification of cerebrovascular reserve in patients with cerebrovascular disease – is there still a role for scintigraphy?

Článek Determination of cerebrovascular reserve using dipyridamole and brain SPECT

Článek Treatment of patient with accumulating skull metastases in thyroid cancer

Článek What can you see on the image?

Článok vyšiel v časopise

Nuclear Medicine

2014 Číslo 3

Najčítanejšie v tomto čísle